ROLE OF IMMUNOHISTOCHEMISTRY ON CELL BLOCKS, IN PRIMARY PLEURAL EFFUSION
Abstract
Background:Pleural effusion is a common finding in many malignancies.The present study was undertaken to determine the feasibility of cell block immunohistochemistry in cases presented with pleural effusion and finding the accuracy of the same in diagnosing the primary and finding the subtype.
Methods:In this study, out of 200 cases of malignant pleural fluid effusion, 72 cases with no primary diagnosis were taken up. Based on the cytomorphology of conventional smears and cytoblocks cytomorphological diagnosis was offered. An immunopanel CK7, CK5/6, p63, TTF1, calretinin was applied on cell blocks. Additional immunochemical markers were performed based on clinical details and cytomorphology, wherever indicated.
Results: The mean age of the patients was 50.8 years. The male to female ratio was 3.2:1. Cytomorphology was evaluated in all the 72 cases and IHC was used in 59 cases. After IHC 76.27% cases were confirmed as metastasis from lung primary, 10.1% from ovary, 3.3% from stomach and 10.16% from lymphoma. Other cases include mesothelioma(n=2), small cell carcinoma(n=2).
Conclusion: Judicious use of IHC on cytoblocks of pleural fluid is effective in detection of lung carcinoma and its typing and also for detecting primary site in tumors of extrapulmonary origin especially in cases where obtaining a biopsy is technically challenging.
Keywords
Full Text:
PDFReferences
Porcel JM,Palma R,Bielsa S, et al.TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions.Respirology 2015;43:527-531.
Lv M,Leng JH, Hao YY, et al.Expression and significance of MOC-31 and calretinin in pleural fluid of patients with lung cancer.Diag Cytopathol2015;43:527-531.
Kim JH,Kim GE,Choi YD, et al.Immunocytochemical panel for distinguishing between adenocarcinomas and reactive mesothelial cells in effusion cell blocks.Diagn Cytopathol 2009;37:258-261.
Ramalingam S,Pawlish K,Gadgeel S, Demers R, Kalemkerian GP.Lung cancer in young patients: analysis of a surveillance,epidemiology, and end results database. J Clin Oncol 1998;16:651-657.
Hsu CH,Tseng CH, Cjhiang Cj, et al.Characteristics of young lung cancer:Analysis of Taiwan’s nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status. Oncotarget 2016;7:46628-46635.
The American Thoracic Society and The European Respiratory Society. Pretreatment evaluation of non small cell lung cancer.Am J Respir Crit Care Med 1997;156:320-332.
Livingston RB, McCracken JD, Trauth CJ,Chen T.Isolated pleural effusion in small cell lung carcinoma:favorable prognosis. A review of the Southwest Oncology Group experience. Chest 1982;81:208-211.
de Hoop B,Schaefer-Prokop C,Gietema HA, et al. Screening for lung cancer with digital chest radiography:Sensitivity and number of secondary work-up CT examinations.Radiology 2010;255:629-637.
Kulshrestha R, Vijayan VK.Immunohistochemical staining on fine needle aspiration biopsy-cell block specimens in the differential diagnosis of lung cancers. Indian J Chest Dis Allied Sci 2009;51:21-25.
Brown AF,Sirohi D, Fukuoka J, et al. Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma,adenocarcinoma, and small cell carcinoma of lung. Arch Patho Lab Med 2013;137:1274-1281.
Kargi A, Gurel D, Tuna B.The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas. Appl Immunohistochem Mol Morphol 2007;15:415-420.
Khayyata S, Yun S, Pasha T,et al.Value of p63 and CK 5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine needle aspiration specimens.Diagn Cytopathol 2009;37:178-183.
Xu X,Liu H,Jiang H,Li C, Yuan S, Yang J. Combined detection of thyroid transcription factor I and napsin Ain pleural fluid cell blocks facilitates cytopatholoic diagnosis of pulmonary adenocarcinoma.Nan Fang Yi Ke Da Xue Xue Bao 2015;35:1610-1613.
Kim JHI, Choi YD, Lee JS, Lee JH, Nam JH, Choi C.Utility of thyroid transcription factor-1 and CDX-2 in determining the primary site of metastatic adenocarcinoma in serous effusions. Acta cytol 2010;54:277-282.
Refbacks
- There are currently no refbacks.